JX Luxventure Limited (JXJT) has cured its bid deficiency, which means it has met the minimum bid requirement for continued listing on the Nasdaq Capital Market. This is positive news for the company as it ensures its stock will continue to be listed and traded on Nasdaq, potentially attracting more investors and improving its stock price in the short term.